Domainex successful in securing Biomedical Catalyst Feasibility Award

Domainex successful in securing Biomedical Catalyst Feasibility Award

Eighteen SMEs have been awarded funding totalling nearly £2.5 million by the Technology Strategy Board to carry out feasibility studies. These awards will enable the companies to explore and evaluate the commercial potential of an early-stage scientific idea, to validate the scientific concepts, fully test the market opportunity and construct future development plans.